Vascular endothelial growth factor levels in the aqueous and serum in diabetic retinopathy with or without neovascular glaucoma

Journal of Japanese Ophthalmological Society

Volumn 102, Issue 11, 1998, Pages 731-738

  Kozawa, Tadahiko ^a   Sone, Hirohito ^b   Okuda, Yukichi ^b   Kawakami, Yasushi ^b   Sekine, Yasuo ^b   Imai, Masayuki ^a   Hommura, Sachiko ^b   Inatomi, Makoto ^a   Yaguchi, Shigeo ^c   Matsuo, Katsuhiko ^d   Segawa, Toshiaki ^d   Suzuki, Hideo ^d   Yamashita, Kamejiro ^b  

^a Kozawa Hospital

^b UNIVERSITY OF TSUKUBA   (Japan)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^d Base Technology Center

Author keywords

Angiogenesis; Cytokine; Diabetic retinopathy; Neovascular (rubeotic) glaucoma; Vascular endothelial growth factor; Vascular permeability factor; VEGF; VPF

Indexed keywords

CYTOKINE; VASCULOTROPIN;

ANGIOGENESIS; AQUEOUS HUMOR FLOW; ARTICLE; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; IRIS RUBEOSIS; NEOVASCULAR GLAUCOMA; PATHOGENESIS; TREATMENT PLANNING;

ADULT; AGED; AQUEOUS HUMOR; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; FEMALE; GLAUCOMA, NEOVASCULAR; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 7844220230     PISSN: 00290203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Folkman J, Shing Y : Angiogenesis. J Biol Chem 267 : 10931-10934, 1992.
2. Neufeld G, Tessler S, Gitay GH, Cohen T, Levi BZ : Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 5 : 89-97, 1994.
3. Ferrara N, Houck K, Jakeman L, Leung DW : Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 : 18-32, 1992.
4. Yeo TK, Senger DR, Dvorak HF, Freter L, Yeo KT : Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochem Biophys Res Commun 179 : 1568-1575, 1991.
5. Tischer E, Gospodarowicz D, Mitchell R, Silva M, Schilling J, Lau K. et al : Vascular endothelial growth factor : A new member of the platelet derived growth factor gene family. Biochem Biophys Res Commun 165 : 1198-1206, 1989.
6. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW : The vascular endothelial growth factor family : Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5 : 1806-1814, 1991.
7. Houck KA, Leung DW, Rowland AM, Winer J. Ferrara N : Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267 : 26031-26037, 1992.
8. Jakeman LB, Armanini M, Phillips HS, Ferrara N : Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133 : 848-859, 1993.
9. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al : Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152 : 4149 4156, 1994.
10. Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, et al : Stimulation by thyroid stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and fi⊤ mRNA expression in the rat thyroid in vivo. J Clin Invest 96 : 1295-1302, 1995.
11. McClure N, Healy DL, Rogers PA, Sullivan J, Beaton L, Haning RJ, et al : Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 341 : 235-236, 1994.
12. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H : Vascular endothelial growth factor vascular permeability factor is detectable in the sera of tumor - bearing mice and cancer patients. Biochim Biophys Acta 1221 : 211-214, 1994.
13. Hanatani M, Tanaka Y, Kondo S, Omori I, Suzuki H : Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci Biotech Biochem 59 : 1958-1959, 1995.
14. Merimee TJ, Zapf J, Froesch ER : Insulin - like growth factors. Studies in diabetics with and with-out retinopathy. N Engl J Med 309 : 527-530, 1983.
15. Kondo S, Asano M, Suzuki H : Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 194 : 1234-1241, 1993.
16. Grant M, Russell B, Fitzgerald C, Merimee TJ : Insulin - like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization. Diabetes 35 : 416-420, 1986.
17. Meyer SR, Pfeiffer A, Blum WF, Freyberger H, Klein M, Losche C, et al : Vitreous levels of the insulin - like growth factors I and II. and the insulin - like growth factor binding proteins 2 and 3. increase in neovascular eye disease. Studies in non-diabetic and diabetic subjects. J Clin Invest 92 : 2620-2625, 1993.
18. Kauffmann DJH, van Meurs JC, Mertens DAE, Peperkamp E, Master C, Gerritsen ME : Cytokines in vitreous humor : Interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 35 : 900-906, 1994.
19. Baird A, Culler F, Jones KL, Guillemin R : Angiogenic factor in human ocular fluid. Lancet 2 (8454) : 563, 1985.
20. Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L : Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 108 : 869-872, 1990.
21. Chen CH, Chen SC : Evidence of the presence of a specific vascular endothelial growth factor in fetal bovine retina. Exp Cell Res 169 : 287-295, 1987.
22. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E : Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 72 : 638-645, 1995.
23. Shima DT, Adamis AP, Ferrara N, Yeo KT, Yeo TK, Allende R, et al : Hypoxic induction of endothelial cell growth factors in retinal cells : Identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med 1 : 182-193, 1995.
24. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA : Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113 : 1538-1544, 1995.
25. Hata Y, Nakagawa K, Ishibashi T, Inomata H, Ueno H, Sueishi K : Hypoxia - induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Arch 426 : 479-486, 1995.
26. Shweiki D, Itin A, Soffer D, Keshet E : Vascular endothelial growth factor induced by hypoxia may mediate hypoxia - initiated angiogenesis. Nature 359 : 843-845, 1992.
27. Brogi E, Wu T, Namiki A, Isner JM : Indirect an giogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90 : 649-652, 1994.
28. Minchenko A, Salceda S, Bauer T, Caro J : Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 40 : 35-39, 1994.
29. Minchenko A, Bauer T, Salceda S, Caro J : Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71 : 374-379, 1994.
30. Sonc H, Kawakami Y, Okuda Y, Kondo S, Hanatani M, Suzuki H, et al : Vascular endothelial growth factor (VEGF) is induced by chronic high glucose concentration and upregulated by acute glucose deprivation in cultured bovine retinal pigment epithelial cells. Biochem Biophys Res Commun 221 : 193-198, 1996.
31. Sone H, Kawakami Y, Okuda Y, Kondo S, Hanatani M,Matsuo K, et al : Induction of vascular endothelial growth factor (VEGF) production by progesterone on cultured retinal pigment epithelial cells. Life Sci 59 : 21-25, 1996.
32. Adamis AP, Miller JW, Bernai MT, D'Amico DJ, Folkman J, Yeo TK, et al : Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118 : 445-450, 1994.
33. Plouet J, Chollet P, Moro F, Malecaze F : Secretion of VAS VEGF by retinal pericytes : A paracrine stimulation of endothelial cell proliferation. Invest Ophthalmol Vis Sci 34 : 900 (ARVO Abstracts). 1993.
34. Malecaze F, Clamens S, Simorre PV, Mathis A, Chollet P, Favard C, et al : Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor like activity in proliferative diabetic retinopathy. Arch Ophthalmol 112 : 1476-1482, 1994.
35. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al : Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 : 1480-1487, 1994.
36. Rehak J : Neovascular glaucoma and intraocular pressure.I.Pathogenesis of increased intraocular pressure and therapy (a review of historical and current therapeutic modalities). Acta Univ Palacki Olomuc Fac Med 133 : 71 73, 1992.
37. Tolentino MJ , Miller JW , Gragoudas ES , Chatzistefanou K,Ferrara N,Adamis AP : Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in nonhuman primate. Arch Ophthalmol 114 : 964-970, 1996.
38. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I : Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347 : 702, 1996.
39. Burgos R, Simo R, Audi L, Mateo C, Mesa J, Garcia-Ramirez M, et al : Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia 40 : 1107-1109, 1997.
40. Lev RA, Hwang DL : Epidermal growth factor and platelet-derived growth factor in blood in diabetes mellitus. Acta Endocrinol (Copenh) 123 : 326-330, 1990.
41. Hyer SL, Sharp PS, Brooks RA, Burrin JM, Kohner EM : Serum IGF-1 concentration in diabetic retinopathy. Diabet Med 5 : 356-360, 1988.
42. Hyer SL, Sharp PS, Brooks RA, Burrin JM, Kohner EM : A two-year follow-up study of serum insulin-like growth factor-1 in diabetics with retinopathy. Metabolism 38 : 586-589, 1989.